Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The lyophilized vial itself should be held at -20C for long-term stability
In WT and obese animals, AOD9604 reduces fat mass, increases 3-AR expression, enhances lipolysis, and stimulates energy expenditure and fat oxidation
It is not listed on the 503B compounding bulk substances list (per FDA Warning Letter, Jan 2026)
Side effects are rare but may include: Mild pain or redness at the injection site Headache Dizziness Upset stomach Reactions are highly uncommon
Its effects stay focused on adipose tissue: AOD9604 stimulates lipolysis primarily through beta3 adrenergic receptor pathways in adipose tissue, driving the breakdown of stored triglycerides into free fatty acids
US$ 20.65
US$ 20.26
US$ 26.44
